Valeant Chief Says Timing of His Return to Work Is Unclear by ANDREW POLLACK

By ANDREW POLLACK

J. Michael Pearson, who is also Valeant’s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.

Published: January 26, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1NuVzCp

from WordPress http://ift.tt/1KzE6IV
via Hadi Aboukhater